An Active Surveillance Study to Monitor the Safety of Abrocitinib Among Real-World Patients with Atopic Dermatitis (AD) in the European Union (EU)First published 30/10/2024 Last updated 07/01/2025 EU PAS number: EUPAS1000000282StudyOngoing
Aarhus University & Aarhus University Hospital DEPARTMENT OF CLINICAL EPIDEMIOLOGYDenmark First published: 20/07/2021Last updated 02/04/2024 InstitutionEducational InstitutionENCePP partner
Centre for Pharmacoepidemiology, Karolinska Institutet (CPE-KI)Sweden First published: 24/03/2010Last updated 23/04/2024 InstitutionEducational InstitutionLaboratory/Research/Testing facilityNot-for-profitENCePP partner
Bordeaux PharmacoEpi, University of BordeauxFrance First published: 07/02/2023Last updated 08/02/2023 InstitutionEducational InstitutionHospital/Clinic/Other health care facilityNot-for-profitENCePP partner
The SIGMA Consortium (SIGMA)DenmarkEuropean UnionFranceGermanyItalyNetherlandsNorwaySpainSwedenUnited Kingdom First published: 10/02/2013Last updated 16/12/2024 NetworkENCePP partner